Abstract
Purpose
This study compared the outcomes of a limbal conjunctival autograft (LCAG) with those of an amniotic membrane graft (AMG) followed by intraoperative 0.02 % mitomycin C (MMC) to treat recurrent pterygium.
Methods
In this randomized controlled trial, ninety-six eyes with recurrent pterygium were enrolled and randomly allocated into two groups using a computer-generated random number table. Pterygium removal was followed by intraoperative 0.02 % MMC for 3 min and then either LCAG or AMG transplantation. The major outcomes were recurrence rate, conjunctival inflammation grade, healing time of the corneal epithelial defect, eye-movement amplitude (EMA), uncorrected distance visual acuity (UDVA), and complications.
Results
A follow-up of 12 months was conducted for 93 eyes of 82 patients. Grade D (recurrence) presented in one eye of the LCAG group and five eyes of the AMG group, with no between-group difference (p = 0.196). However, Grades A, B, and C presented in 46, zero and zero eyes of the LCAG group respectively, and in 37, two and two eyes of the AMG group respectively, with the surgical bed generally showing a better appearance in the LCAG group than in the AMG group (p = 0.008). Compared with baseline values, the postoperative EMA improved significantly in both groups (p < 0.001 for the LCAG group; p = 0.001 for the AMG group), as did UDVA (p = 0.005 for the LCAG group; p = 0.012 for the AMG group). No between-group differences were found in terms of the healing time for epithelial defect, conjunctival inflammation grade, or the frequency of complications such as punctate epithelial keratitis, episcleral melting, corneal pannus, and delayed corneal epithelium healing.
Conclusions
LCAG transplantation with intraoperative 0.02 % MMC is as efficacious in treating recurrent pterygium as AMG transplantation with MMC. The former procedure results in an attractive cosmetic appearance but might result in limbal damage in some eyes. The surgeon’s familiarity with these procedures should determine the method of treatment.
Similar content being viewed by others
References
Hirst LW (2003) The treatment of pterygium. Surv Ophthalmol 48:145–180. doi:10.1016/S0039-6257(02)00463-0
Shimazaki J, Shinozaki N, Tsubota K (1998) Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol 82:235–240. doi:10.1136/bjo.82.3.235
Shimazaki J, Kosaka K, Shimmura S, Tsubota K (2003) Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium. Ophthalmology 110:119–124. doi:10.1016/S0161-6420(02)01453-7
Dekaris I, Gabrić N, Karaman Z, Mravicić I, Kastelan S (2002) Limbal-conjunctival autograft transplantation for recurrent pterygium. Eur J Ophthalmol 12:177–182
Tan DT, Chee SP, Dear KB, Lim AS (1997) Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 115:1235–1240. doi:10.1001/archopht.1997.01100160405001
Verma N, Garap JA, Maris R, Kerek A (1998) Intraoperative use of mitomycin C in the treatment of recurrent pterygium. P N G Med J 41:37–42
Mastropasqua L, Carpineto P, Ciancaglini M, Enrico Gallenga P (1996) Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium. Br J Ophthalmol 80:288–291. doi:10.1136/bjo.80.4.288
Lam DS, Wong AK, Fan DS, Chew S, Kwok PS, Tso MO (1998) Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study. Ophthalmology 105:901–904. doi:10.1016/S0161-6420(98)95034-5 [Discussion:904–905]
Kaufman SC, Jacobs DS, Lee WB, Deng SX, Rosenblatt MI, Shtein RM (2013) Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology. Ophthalmology 120:201–208. doi:10.1016/j.ophtha.2012.06.066
Al Fayez MF (2002) Limbal versus conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 109:1752–1755. doi:10.1016/S0161-6420(02)01160-0
Dekaris I, Gabrić N, Karaman Z, Mravicić I, Kastelan S, Spoljarić N (2001) Pterygium treatment with limbal-conjunctival autograft transplantation. Coll Anthropol 25(Suppl):7–12
Gris O, Güell JL, del Campo Z (2000) Limbal–conjunctival autograft transplantation for the treatment of recurrent pterygium. Ophthalmology 107:270–273. doi:10.1016/S0161-6420(99)00041-X
Rao SK, Lekha T, Mukesh BN, Sitalakshmi G, Padmanabhan P (1998) Conjunctival–limbal autografts for primary and recurrent pterygia: technique and results. Indian J Ophthalmol 46:203–209
Mutlu FM, Sobaci G, Tatar T, Yildirim E (1999) A comparative study of recurrent pterygium surgery: limbal conjunctival autograft transplantation versus mitomycin C with conjunctival flap. Ophthalmology 106:817–821. doi:10.1016/S0161-6420(99)90172-0
Salman AG, Mansour DE (2011) The recurrence of pterygium after different modalities of surgical treatment. Saudi J Ophthalmol 25:411–415. doi:10.1016/j.sjopt.2010.10.013
Prabhasawat P, Barton K, Burkett G, Tseng SC (1997) Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 104:974–985. doi:10.1016/S0161-6420(97)30197-3
Solomon A, Pires RT, Tseng SC (2001) Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology 108:449–460. doi:10.1016/S0161-6420(00)00567-4
Ma DH, See LC, Hwang YS, Wang SF (2005) Comparison of amniotic membrane graft alone or combined with intraoperative mitomycin C to prevent recurrence after excision of recurrent pterygia. Cornea 24:141–150. doi:10.1097/01.ico.0000141237.71837.d8
Fakhry MA (2011) The use of mitomycin C with autologous limbal-conjunctival autograft transplantation for management of recurrent pterygium. Clin Ophthalmol 5:123–127. doi:10.2147/OPTH.S16474
Yao Y-F, Qiu W-Y, Zhang Y-M, Tseng SC (2006) Mitomycin C, amniotic membrane transplantation and limbal conjunctival autograft for treating multirecurrent pterygia with symblepharon and motility restriction. Graefes Arch Clin Exp Ophthalmol 244:232–236. doi:10.1007/s00417-005-0010-y
Nabawi KS, Ghonim MA, Ali MH (2003) Evaluation of limbal conjunctival autograft and low-dose mitomycin C in the treatment of recurrent pterygium. Ophthalmic Surg Lasers Imaging 34:193–196
Katircioğlu YA, Altiparmak UE, Duman S (2007) Comparison of three methods for the treatment of pterygium: amniotic membrane graft, conjunctival autograft and conjunctival autograft plus mitomycin C. Orbit 26:5–13. doi:10.1080/01676830600972724
Zheng K, Cai J, Jhanji V, Chen H (2012) Comparison of pterygium recurrence rates after limbal conjunctival autograft transplantation and other techniques: meta-analysis. Cornea 31:1422–1427. doi:10.1097/ICO.0b013e31823cbecb
Kheirkhah A, Hashemi H, Adelpour M, Nikdel M, Rajabi MB, Behrouz MJ (2012) Randomized trial of pterygium surgery with mitomycin C application using conjunctival autograft versus conjunctival-limbal autograft. Ophthalmology 119:227–232. doi:10.1016/j.ophtha.2011.08.002
Young AL, Ho M, Jhanji V, Cheng LL (2013) Ten-year results of a randomized controlled trial comparing 0.02% mitomycin C and limbal conjunctival autograft in pterygium surgery. Ophthalmology 120:2390–2395. doi:10.1016/j.ophtha.2013.05.033
Hirst LW (2009) Recurrent pterygium surgery using pterygium extended removal followed by extended conjunctival transplant: recurrence rate and cosmesis. Ophthalmology 116:1278–1286. doi:10.1016/j.ophtha.2009.01.044
Zhou S, Chen J, Feng J (2003) The effects of amniotic membrane on polymorphonuclear cells. Chin Med J (Engl) 116:788–790
Kheirkhah A, Casas V, Sheha H, Raju VK, Tseng SC (2008) Role of conjunctival inflammation in surgical outcome after amniotic membrane transplantation with or without fibrin glue for pterygium. Cornea 27:56–63. doi:10.1097/ICO.0b013e31815873da
Wei S, Chan L, Cui Y (2005) Limbal epithelial autograft and amniotic membrane transplantation for pterygium in 107 cases. Int J Ophthalmol 5:583–585
Sippel KC, Ma JJ, Foster CS (2001) Amniotic membrane surgery. Curr Opin Ophthalmol 12:269–281. doi:10.1097/00055735-200108000-00006
Katırcıoglu YA, Altiparmak U, Engur Goktas S, Cakir B, Singar E, Ornek F (2015) Comparison of two techniques for the treatment of recurrent pterygium: amniotic membrane vs conjunctival autograft combined with mitomycin C. Semin Ophthalmol 30:321–327. doi:10.3109/08820538.2013.874468
Ratnalingam V, Eu AL, Ng GL, Taharin R, John E (2010) Fibrin adhesive is better than sutures in pterygium surgery. Cornea 29:485–489. doi:10.1097/ICO.0b013e3181c29696
Sridhar MS, Vemuganti GK, Bansal AK, Rao GN (2001) Impression cytology-proven corneal stem cell deficiency in patients after surgeries involving the limbus. Cornea 20:145–148. doi:10.1097/00003226-200103000-00005
Kheirkhah A, Nazari R, Nikdel M, Ghassemi H, Hashemi H, Behrouz MJ (2011) Postoperative conjunctival inflammation after pterygium surgery with amniotic membrane transplantation versus conjunctival autograft. Am J Ophthalmol 152:733–738. doi:10.1016/j.ajo.2011.04.013
Dua HS (1998) The conjunctiva in corneal epithelial wound healing. Br J Ophthalmol 82:1407–1411. doi:10.1136/bjo.82.12.1407
Dua HS, Azuara-Blanco A (2000) Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency. Br J Ophthalmol 84:273–278. doi:10.1136/bjo.84.3.273
McCluskey P, Powell RJ (2004) The eye in systemic inflammatory diseases. Lancet 364(9451):2125–2133. doi:10.1016/S0140-6736(04)17554-5
Tsai YY, Lin JM, Shy JD (2002) Acute scleral thinning after pterygium excision with intraoperative mitomycin C: a case report of scleral dellen after bare sclera technique and review of the literature. Cornea 21:227–229. doi:10.1097/00003226-200203000-00022
Karalezli A, Kucukerdonmez C, Borazan M, Akova YA (2010) Successful treatment of necrotizing scleritis after conjunctival autografting for pterygium with amniotic membrane transplantation. Orbit 29:88–90. doi:10.3109/01676830903297563
Hirst LW, Sebban A, Chant D (1994) Pterygium recurrence time. Ophthalmology 101:755–758. doi:10.1016/S0161-6420(94)31270-X
Acknowledgments
The study was supported in part by “Sun Yat-Sen University Clinical Research 5010 Program” in China (grant number: 2014015). This funding organization played no role in the design or performance of this research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The “Sun Yat-Sen University Clinical Research 5010 Program” in China (grant number: 2014015) funded this study.
Conflict of interest
The authors declare no financial or non-financial conflicts of interest. The authors had full control over the primary data, and they agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data upon request.
Ethical approval
All of the procedures performed in studies involving human participants were conducted in accordance with the ethical standards of the institutional and/or national research committees and in light of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all participants included in this study.
Additional information
This study was registered at http://www.clinicaltrials.gov (ClinicalTrials.gov identifier: NCT01319721).
Rongxin Chen, Guofu Huang, and Shu Liu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Chen, R., Huang, G., Liu, S. et al. Limbal conjunctival versus amniotic membrane in the intraoperative application of mitomycin C for recurrent pterygium: a randomized controlled trial. Graefes Arch Clin Exp Ophthalmol 255, 375–385 (2017). https://doi.org/10.1007/s00417-016-3509-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-016-3509-5